Cargando…

Herpes zoster in SLE: prevalence, incidence and risk factors

OBJECTIVES: This study aimed to evaluate the prevalence and incidence of herpes zoster (HZ) events and describe its associated factors in a study of patients with SLE. METHODS: 491 consecutive SLE participants were screened for HZ events using a patient-reported questionnaire to capture outcomes on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Andrew, Rayes, Hanan Al, Lazova, Tijana, Anderson, Nicole, Bonilla, Dennisse, Su, Jiandong, Touma, Zahi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753438/
https://www.ncbi.nlm.nih.gov/pubmed/35017186
http://dx.doi.org/10.1136/lupus-2021-000574
_version_ 1784632096458801152
author Kwan, Andrew
Rayes, Hanan Al
Lazova, Tijana
Anderson, Nicole
Bonilla, Dennisse
Su, Jiandong
Touma, Zahi
author_facet Kwan, Andrew
Rayes, Hanan Al
Lazova, Tijana
Anderson, Nicole
Bonilla, Dennisse
Su, Jiandong
Touma, Zahi
author_sort Kwan, Andrew
collection PubMed
description OBJECTIVES: This study aimed to evaluate the prevalence and incidence of herpes zoster (HZ) events and describe its associated factors in a study of patients with SLE. METHODS: 491 consecutive SLE participants were screened for HZ events using a patient-reported questionnaire to capture outcomes on pain and other characteristics associated with HZ events. Sociodemographic, clinical and laboratory measures were also analysed, and time-dependent Cox regression survival analyses were performed to investigate factors associated with HZ events. RESULTS: Prevalence of HZ was 30.5%, incidence was 14.3 cases per 1000 person-years. Lymphopenia and glucocorticoid dosing were significantly associated with HZ events. CONCLUSIONS: HZ is highly prevalent in SLE, which may be linked to disease-related and treatment-related effects on cellular immunity. Our results suggest that the presence of certain risk factors may be useful to allow identification of patients at risk of HZ and improve its management in patients with SLE.
format Online
Article
Text
id pubmed-8753438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87534382022-01-26 Herpes zoster in SLE: prevalence, incidence and risk factors Kwan, Andrew Rayes, Hanan Al Lazova, Tijana Anderson, Nicole Bonilla, Dennisse Su, Jiandong Touma, Zahi Lupus Sci Med Epidemiology and Outcomes OBJECTIVES: This study aimed to evaluate the prevalence and incidence of herpes zoster (HZ) events and describe its associated factors in a study of patients with SLE. METHODS: 491 consecutive SLE participants were screened for HZ events using a patient-reported questionnaire to capture outcomes on pain and other characteristics associated with HZ events. Sociodemographic, clinical and laboratory measures were also analysed, and time-dependent Cox regression survival analyses were performed to investigate factors associated with HZ events. RESULTS: Prevalence of HZ was 30.5%, incidence was 14.3 cases per 1000 person-years. Lymphopenia and glucocorticoid dosing were significantly associated with HZ events. CONCLUSIONS: HZ is highly prevalent in SLE, which may be linked to disease-related and treatment-related effects on cellular immunity. Our results suggest that the presence of certain risk factors may be useful to allow identification of patients at risk of HZ and improve its management in patients with SLE. BMJ Publishing Group 2022-01-11 /pmc/articles/PMC8753438/ /pubmed/35017186 http://dx.doi.org/10.1136/lupus-2021-000574 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology and Outcomes
Kwan, Andrew
Rayes, Hanan Al
Lazova, Tijana
Anderson, Nicole
Bonilla, Dennisse
Su, Jiandong
Touma, Zahi
Herpes zoster in SLE: prevalence, incidence and risk factors
title Herpes zoster in SLE: prevalence, incidence and risk factors
title_full Herpes zoster in SLE: prevalence, incidence and risk factors
title_fullStr Herpes zoster in SLE: prevalence, incidence and risk factors
title_full_unstemmed Herpes zoster in SLE: prevalence, incidence and risk factors
title_short Herpes zoster in SLE: prevalence, incidence and risk factors
title_sort herpes zoster in sle: prevalence, incidence and risk factors
topic Epidemiology and Outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753438/
https://www.ncbi.nlm.nih.gov/pubmed/35017186
http://dx.doi.org/10.1136/lupus-2021-000574
work_keys_str_mv AT kwanandrew herpeszosterinsleprevalenceincidenceandriskfactors
AT rayeshananal herpeszosterinsleprevalenceincidenceandriskfactors
AT lazovatijana herpeszosterinsleprevalenceincidenceandriskfactors
AT andersonnicole herpeszosterinsleprevalenceincidenceandriskfactors
AT bonilladennisse herpeszosterinsleprevalenceincidenceandriskfactors
AT sujiandong herpeszosterinsleprevalenceincidenceandriskfactors
AT toumazahi herpeszosterinsleprevalenceincidenceandriskfactors